Yes-associated protein (YAP) expression is involved in epithelial-mesenchymal transition in hepatocellular carcinoma

S Wang1,2, H Li1, G Wang1

  • 1Department of Hepatic Surgery, Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe District, Guangzhou, 510630, Guangdong, China.

Abstract

Insights

Downregulating yes-associated protein (YAP) in hepatocellular carcinoma cells reduced invasion and altered epithelial-mesenchymal transition markers. YAP is closely linked to E-cadherin and N-cadherin expression in these cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Epithelial-mesenchymal transition (EMT) is a critical process in cancer progression and metastasis.
  • Yes-associated protein (YAP) is a key regulator of cell proliferation and tissue growth, implicated in various cancers.
  • Understanding YAP's role in EMT is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the biological impact of downregulating yes-associated protein (YAP) via RNA interference.
  • To examine the effect of YAP downregulation on epithelial-mesenchymal transition (EMT) markers in MHCC97H and MHCC97L hepatocellular carcinoma cell lines.

Main Methods:

  • MHCC97H and MHCC97L cells were transfected with YAP-siRNA.
  • Protein and mRNA levels of E-cadherin and N-cadherin were analyzed using Western blotting and real-time PCR.
  • Cell invasiveness was assessed via Transwell invasion assays.

Main Results:

  • YAP silencing significantly increased E-cadherin expression in MHCC97H and MHCC97L cells.
  • N-cadherin expression decreased in MHCC97H but showed no significant change in MHCC97L cells.
  • Cell invasiveness was significantly reduced in both cell lines after YAP downregulation.

Conclusions:

  • YAP expression is closely associated with EMT markers, specifically E-cadherin and N-cadherin, in hepatocellular carcinoma.
  • Downregulation of YAP impacts EMT and reduces the invasive potential of MHCC97H and MHCC97L cells.
  • The findings suggest YAP as a potential therapeutic target for hepatocellular carcinoma treatment.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
4.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K